Norgine Boosts Drug Manufacturing in Wales with £23 Million Investment In a strategic move to expand operations, Norgine announces a £23 million investment in its Wales facility, totaling over £50 million since 2022, aimed at enhancing medication manufacturing capabilities.

Norgine Boosts Drug Manufacturing in Wales with £23 Million Investment #United_Kingdom #Norgine #Drug_Manufacturing #Wales #Hengoed

Frontage Laboratories Unveils New GMP Facility for Clinical Trials and Production Frontage Laboratories announces the opening of its new GMP facility, focusing on efficient drug development and manufacturing for clinical trials and commercial production.

Frontage Laboratories Unveils New GMP Facility for Clinical Trials and Production #United_States #Exton,_Pennsylvania #Drug_Manufacturing #GMP_Facility #Frontage_Laboratories

Alcami Announces Expansion of Drug Manufacturing Capacity to Meet Rising Market Demand Alcami Corporation expands its drug product manufacturing capacity with a new sterile fill-finish line, meeting increasing demands in the pharmaceutical industry.

Alcami Announces Expansion of Drug Manufacturing Capacity to Meet Rising Market Demand #USA #Durham #Alcami_Corporation #Drug_Manufacturing #sterile_fill-finish_line

INCOG BioPharma Expands Operations with Massive $200 Million Investment INCOG BioPharma is set to expand its operations in Fishers, Indiana, investing $200 million to increase its workforce to nearly 1,000 employees by 2030.

INCOG BioPharma Expands Operations with Massive $200 Million Investment #United_States #Fishers #Drug_Manufacturing #Fishers_Indiana #INCOG_BioPharma

Eli Lilly to Invest Over $1.2 Billion in Puerto Rico to Boost Oral Drug Manufacturing Eli Lilly & Company announces a strategic investment of over $1.2 billion in Puerto Rico, increasing oral drug manufacturing capacity while creating new jobs.

Eli Lilly to Invest Over $1.2 Billion in Puerto Rico to Boost Oral Drug Manufacturing #United_States #Puerto_Rico #Eli_Lilly #Carolina #Drug_Manufacturing

Piramal Pharma's $90 Million Investment Expands U.S. Facilities with Focus on Drug Manufacturing Piramal Pharma Ltd. invests $90 million in expanding two U.S. sites, enhancing capabilities for sterile injectables and drug development, underpinning commitment to innovation.

Piramal Pharma's $90 Million Investment Expands U.S. Facilities with Focus on Drug Manufacturing #USA #Piramal_Pharma #Drug_Manufacturing #ADCelerate #Lexington,_Michigan

AST's 60th Anniversary: A Legacy of Innovation in Drug Manufacturing AST commemorates its 60th anniversary at INTERPHEX 2025, reflecting on its history of innovation in drug product manufacturing while looking ahead to future advancements.

AST's 60th Anniversary: A Legacy of Innovation in Drug Manufacturing #USA #Tacoma #AST #Drug_Manufacturing #Aseptic_Technology